The "HLA - Celiac Disease DR-DQB1-DQA1 Haplotype Association Including DQ2DQ8 Test" is a specialized genetic test offered at DNA Labs UAE, designed to identify the presence of specific human leukocyte antigen (HLA) haplotypes that are strongly associated with celiac disease. Celiac disease is an autoimmune disorder where ingestion of gluten leads to damage in the small intestine. The key HLA haplotypes involved are HLA-DQ2 and HLA-DQ8, which are found in the majority of individuals with celiac disease.
This test examines the patient's DNA to check for the presence of these haplotypes by analyzing the specific alleles at the DR, DQB1, and DQA1 loci, which are part of the HLA system. Identifying these haplotypes can be crucial for diagnosing celiac disease, as their presence significantly increases the likelihood of the condition, although not all individuals with these haplotypes will develop the disease.
The cost of the test is 1330 AED, reflecting the advanced genetic analysis involved. Conducted at DNA Labs UAE, this test is a valuable tool for clinicians in diagnosing celiac disease, enabling a more personalized approach to managing the condition, including dietary recommendations and monitoring for related health issues. It is particularly useful for individuals with symptoms of celiac disease or those with a family history of the condition, providing crucial insights into their genetic predisposition to developing this autoimmune disorder.
The "Small Biopsy Bottle No 11 Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to analyze small tissue samples for various medical purposes. This test is crucial for diagnosing diseases, including cancer, by examining cells and tissues in a small biopsy sample. The process involves collecting a tiny amount of tissue using a biopsy bottle labeled "No 11," which is then sent to the lab for detailed examination. DNA Labs UAE, known for its state-of-the-art technology and expert analysis, ensures accurate and reliable results. The cost of the test is 1330 AED, making it accessible for patients needing advanced diagnostic services. This test is essential for early detection and treatment planning of various conditions, providing patients and healthcare providers with critical information for managing health effectively.
The "Insulin Free Bioactive Test" is a specialized diagnostic procedure designed to measure the levels of bioactive insulin in the body. This test is particularly crucial for individuals with diabetes or those at risk of developing diabetes, as it helps in assessing the effectiveness of the insulin present in the body and its ability to regulate blood sugar levels. The test involves a simple blood draw, and the sample is analyzed to determine the bioactive insulin levels, providing valuable insights into the patient's insulin activity and overall metabolic health.
Conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic services and state-of-the-art laboratory technologies, this test ensures high accuracy and reliability. The cost of the "Insulin Free Bioactive Test" at DNA Labs UAE is 1110 AED, reflecting the sophisticated nature of the analysis and the detailed insights it provides into the patient's health status. This test is an essential tool for personalized treatment planning and management of diabetes, enabling healthcare providers to tailor interventions more effectively.
The Doxepin Test is a specialized medical examination conducted to detect and measure the levels of Doxepin, a tricyclic antidepressant, in the body. This test is crucial for individuals who are prescribed Doxepin for the treatment of depression, anxiety disorders, or insomnia, as it helps in monitoring the drug's concentration in the bloodstream to ensure therapeutic efficacy and avoid potential toxicity. The test is performed by collecting a blood sample from the patient, which is then analyzed using advanced laboratory techniques.
At DNA Labs UAE, a leading healthcare and diagnostic center, the Doxepin Test is offered as part of their comprehensive suite of diagnostic services. The test is conducted by experienced professionals using state-of-the-art equipment to ensure accurate and reliable results. The cost of the Doxepin Test at DNA Labs UAE is 1320 AED, reflecting the quality and precision of the diagnostic services provided.
Patients opting for this test at DNA Labs UAE can expect a seamless and comfortable experience, with guidance provided throughout the testing process. The results of the test are typically available within a few days, allowing for prompt adjustments to the patient's medication regimen if necessary. This test is a valuable tool for healthcare providers in optimizing the treatment plan for patients taking Doxepin, ensuring both safety and effectiveness in managing their conditions.
The "FISH - t(8;21) or LSI ETOAML1 Test" is a specialized diagnostic procedure aimed at detecting the translocation between chromosomes 8 and 21, often denoted as t(8;21). This genetic anomaly is particularly significant in the context of acute myeloid leukemia (AML), where it serves as a critical diagnostic and prognostic marker. The test employs Fluorescence In Situ Hybridization (FISH) technology, a powerful technique that allows for the visualization of specific genetic abnormalities within chromosomes, directly in the cells.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test is priced at 1200 AED. This cost covers the sophisticated FISH technique which involves the use of fluorescent probes that specifically bind to the regions of interest on chromosomes 8 and 21. The presence of a fluorescent signal at the expected locations indicates the t(8;21) translocation, providing crucial information for the diagnosis, treatment planning, and prognosis of AML patients.
By offering this test, DNA Labs UAE contributes significantly to the personalized management of leukemia, facilitating targeted therapies that can greatly improve patient outcomes. The accuracy, reliability, and specificity of the FISH - t(8;21) or LSI ETOAML1 Test make it an invaluable tool in the field of medical genetics and oncology.
The "FISH - Opposite Sex BMT XX XY Test" offered by DNA Labs UAE is a specialized diagnostic procedure designed to assess the success of a bone marrow transplant (BMT) by identifying the presence of cells from a donor of the opposite sex in the recipient's bloodstream. This test is particularly relevant in cases where a male patient receives a transplant from a female donor or vice versa.
Fluorescence In Situ Hybridization (FISH) technology is employed in this test to detect specific DNA sequences on the X and Y chromosomes, allowing for the precise identification of male (XY) and female (XX) cells within a sample. This method is highly sensitive and accurate, making it an invaluable tool in post-transplant monitoring. By evaluating the proportion of donor to recipient cells, healthcare providers can assess the transplant's engraftment success and monitor for potential complications.
The test is priced at 1200 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. Patients or healthcare providers interested in this test should contact DNA Labs UAE directly for more detailed information regarding preparation, appointment scheduling, and any specific requirements related to the test.
The "FISH - PDGFR Alpha 4q12 Gene Rearrangement Test" is a sophisticated diagnostic procedure aimed at detecting rearrangements in the PDGFR alpha gene located on chromosome 4q12. This test is particularly important in the context of certain cancers, where such genetic anomalies can drive the disease process or influence treatment strategies. Fluorescence in situ hybridization (FISH) is the technology used to identify these genetic changes, offering a high degree of accuracy and specificity.
Performed at DNA Labs UAE, a leading facility known for its advanced diagnostic capabilities, this test is an essential tool for oncologists and hematologists. It helps in the diagnosis, prognosis, and in some cases, the selection of targeted therapies for patients with conditions linked to PDGFR alpha abnormalities. The cost of the test is set at 1200 AED, reflecting the intricate processes and expertise required to accurately detect gene rearrangements. This investment can be pivotal for patients, potentially guiding more personalized and effective treatment plans.
The "FISH - PDGFR Beta 5q33 Gene Rearrangement Test" is a specialized diagnostic tool employed to detect rearrangements in the PDGFRB gene located on chromosome 5q33. This test is particularly significant in the diagnosis and management of certain hematological malignancies, where the rearrangement of the PDGFRB gene can lead to abnormal cell growth and cancer development. Fluorescence In Situ Hybridization (FISH) is the technique used in this test, offering high specificity and sensitivity in identifying genetic abnormalities at a molecular level.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test provides crucial information that aids healthcare professionals in determining the most appropriate treatment plan for patients affected by conditions associated with PDGFRB gene rearrangements. The cost of the test is set at 1200 AED, reflecting the advanced technology and expertise required to conduct this sophisticated analysis. Through this test, DNA Labs UAE contributes to the personalized approach in medicine, enabling targeted therapies that can significantly improve patient outcomes in the realm of hematologic malignancies.
The FISH (Fluorescence In Situ Hybridization) Postnatal Gender Confirmation Test is a sophisticated diagnostic procedure available at DNA Labs UAE, designed to accurately determine the gender of an infant after birth. This test utilizes the FISH technique, which involves applying fluorescent probes that bind to specific DNA sequences on chromosomes related to gender determination. By examining these chromosomes under a fluorescence microscope, technicians can confirm the gender of the newborn with high precision.
The process is non-invasive and requires only a small sample of the child's cells, typically obtained through a blood draw or a cheek swab. This makes the test not only accurate but also safe and comfortable for the infant.
Priced at 1200 AED, the FISH Postnatal Gender Confirmation Test at DNA Labs UAE is a valuable option for parents seeking confirmation of their child's gender for medical, cultural, or personal reasons. The test's cost reflects the advanced technology and expertise required to conduct it, ensuring that parents receive reliable and accurate results. DNA Labs UAE is known for its commitment to quality and accuracy, making it a trusted choice for this sensitive and important testing.
The "FISH - RARA 17q21 Variant Translocation Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting specific genetic abnormalities associated with certain types of leukemia. FISH, or Fluorescence In Situ Hybridization, is a molecular cytogenetic technique that allows scientists to visualize and map the genetic material in an individual's cells. This particular test focuses on identifying the translocation of the RARA gene located on chromosome 17q21, a genetic anomaly often associated with acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia.
The identification of the RARA gene translocation is crucial for the accurate diagnosis and treatment of APL, as it can significantly influence the therapeutic approach and the patient's prognosis. The test involves the use of fluorescent probes that bind to specific DNA sequences on chromosome 17, allowing for the precise detection of the RARA gene's location and its potential translocation.
DNA Labs UAE offers this advanced diagnostic test for a cost of 1200 AED. The facility is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring high-quality and reliable test results. By providing this test, DNA Labs UAE plays a vital role in the early detection and management of leukemia, contributing to better patient outcomes.
